Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 93

Fractyl finds $100m for series F

Yahoo Japan and Alphabet-backed Fractyl aims to make one of its proposed products a cornerstone therapy for type 2 diabetes, and has now raised about $270m in total.

Jun 21, 2021

Daily Deal Round Up: June 18, 2021

Behavioural health platform developer Brightline captured $72m in a round led by GV, while Gopuff is set to buy Siemens and ST-backed mobility software producer RideOS.

Jun 18, 2021

Lyell Immunopharma laps up $425m in IPO

The GlaxoSmithKline and Celgene-backed immunotherapy developer has floated in the middle of its range on the Nasdaq Global Market.

Jun 18, 2021

Mnemo Therapeutics redeems $91m

Alexandria Venture Investments was among the participants in a series A round for the cellular cancer therapeutics developer.

Jun 18, 2021

Amplitude raises $163m for debut fund

Limited partners including Alexandria Venture Investments and Royal Bank of Canada backed the healthcare technology-focused firm's first fund.

Jun 18, 2021

Daily Deal Round Up: June 17, 2021

11Street and CJ Group contributed to a $71.8m round for on-demand logistics provider Barogo while Eli Lilly helped provide $66m for macrocycle drug developer Circle Pharma.

Jun 17, 2021

Verve Therapeutics beats its way to $267m IPO

GV and Novo-backed cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.

Jun 17, 2021

Umoja draws on SoftBank for $210m

SoftBank Vision Fund 2 co-led a series B round for immunotherapy developer Umoja Biopharma with Cormorant Asset Management.

Jun 17, 2021

Apollo assembles investors for $145m round

The Johnson & Johnson, GSK and AstraZeneca-backed drug developer raised the cash in a Patient Square Capital-led round that took its total funding beyond $200m.

Jun 17, 2021

The Pill Club swallows more series B funds

GV has participated in a $41.9m series B extension for the birth control delivery service, which increased the round's size to $92.9m.

Jun 17, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here